Tag: <span>Twincretin Beats</span>

Home / Twincretin Beats
Post

‘Stunning’ Twincretin Beats Semaglutide in Type 2 Diabetes

Mitchel L. Zoler, PhD June 27, 2021 Tirzepatide, a novel “twincretin” agent, was superior to 1-mg semaglutide treatments for reducing both hemoglobin A1c levels and body weight in patients with type 2 diabetes in a pivotal, 40-week, head-to-head trial with nearly 1,900 randomized patients, one of four positive pivotal trial results reported for tirzepatide at the annual...